期刊文献+
共找到23,058篇文章
< 1 2 250 >
每页显示 20 50 100
Effects of penehyclidine hydrochloride on rat intestinal barrier function during cardiopulmonary bypass 被引量:35
1
作者 Ying-Jie Sun Hui-Juan Cao Qiang Jin Yu-Gang Diao Tie-Zheng Zhang 《World Journal of Gastroenterology》 SCIE CAS CSCD 2011年第16期2137-2142,共6页
AIM:To test the ability of penehyclidine hydrochloride (PHC) to attenuate intestinal injury in a rat cardiopulmonary bypass (CPB) model.METHODS:Male Sprague-Dawley rats were randomly divided into six groups (eight eac... AIM:To test the ability of penehyclidine hydrochloride (PHC) to attenuate intestinal injury in a rat cardiopulmonary bypass (CPB) model.METHODS:Male Sprague-Dawley rats were randomly divided into six groups (eight each):sham-operated control;sham-operated low-dose PHC control (0.6 mg/kg);sham-operated high-dose PHC control (2.0 mg/kg);CPB vehicle control;CPB low-dose PHC (0.6 mg/kg);and CPB high-dose PHC (2.0 mg/kg).Blood samples were collected from the femoral artery 2 h after CPB for determination of plasma diamine oxidase (DAO),D-lactate and endotoxin levels.Spleen,liver,mesenteric lymph nodes and lung were removed for biochemical analyses.Intestinal tissue ultrastructure was examined by electron microscopy.RESULTS:In the sham-operated groups,high-and low-dose-PHC had no significant impact on the levels of DAO,D-lactate and endotoxin,or the incidence of intestinal bacterial translocation (BT).Serum levels of DAO,D-lactate,endotoxin and the incidence of intestinal BT were significantly increased in the surgical groups,compared with the sham-operated groups (0.543 ± 0.061,5.697 ± 0.272,14.75 ± 2.46,and 0/40 vs 1.038 ± 0.252,9.377 ± 0.769,60.37 ± 5.63,and 30/40,respectively,all P < 0.05).PHC alleviated the biochemical and histopathological changes in a dosedependent manner.Serum levels of DAO,D-lactate,and endotoxin and the incidence of intestinal BT in the high-dose PHC group were significantly lower than in the low-dose PHC group (0.637 ± 0.064,6.972 ± 0.349,29.64 ± 5.49,and 14/40 vs 0.998 ± 0.062,7.835 ± 0.330,38.56 ± 4.28,and 6/40,respectively,all P < 0.05).CONCLUSION:PHC protects the structure and function of the intestinal mucosa from injury after CPB in rats. 展开更多
关键词 Penehyclidine hydrochloride Intestinal mucosa injury Cardiopulmonary bypass
下载PDF
Neuroprotection against vascular dementia after acupuncture combined with donepezil hydrochloride:P300 event related potential 被引量:31
2
作者 Qiang Liu Xiu-juan Wang +3 位作者 Zhe-cheng Zhang Rong Xue Ping Li Bo Li 《Neural Regeneration Research》 SCIE CAS CSCD 2016年第3期460-464,共5页
Acupuncture can be used to treat various nervous system diseases.Here,168 vascular dementia patients were orally administered donepezil hydrochloride alone(5 mg/day,once a day for 56 days),or combined with acupunctu... Acupuncture can be used to treat various nervous system diseases.Here,168 vascular dementia patients were orally administered donepezil hydrochloride alone(5 mg/day,once a day for 56 days),or combined with acupuncture at Shenting(DU24),Tianzhu(BL10),Sishencong(Extra),Yintang(Extra),Renzhong(DU26),Neiguan(PC6),Shenmen(HT7),Fengchi(GB20),Wangu(GB12) and Baihui(DU20)(once a day for 56 days).Compared with donepezil hydrochloride alone,P300 event related potential latency was shorter with an increased amplitude in patients treated with donepezil hydrochloride and acupuncture.Mini-Mental State Examination score was also higher.Moreover,these differences in P300 latency were identified within different infarcted regions in patients treated with donepezil hydrochloride and acupuncture.These findings indicate that acupuncture combined with donepezil hydrochloride noticeably improves cognitive function in patients with vascular dementia,and exerts neuroprotective effects against vascular dementia. 展开更多
关键词 nerve regeneration vascular dementia acupuncture donepezil hydrochloride event related potential cognitive function infarct focus neural regeneration
下载PDF
Tumor gene mutations and messenger RNA expression: correlation with clinical response to icotinib hydrochloride in non-small cell lung cancer 被引量:30
3
作者 REN Guan-jun ZHAO Yuan-yua +4 位作者 ZHU Yu-jia XIAO Yi XU Jia-sen SHAN Bin ZHANG Li 《Chinese Medical Journal》 SCIE CAS CSCD 2011年第1期19-25,共7页
Background Molecular targeted drugs is now widely used in non-small cell lung cancer (NSCLC) clinical treatment. Icotinib hydrochloride is a new type of oral epidermal growth factor receptor (EGFR) tyrosine kinase... Background Molecular targeted drugs is now widely used in non-small cell lung cancer (NSCLC) clinical treatment. Icotinib hydrochloride is a new type of oral epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (EGFR-TKIs). In this study, we examined the role of EGFR, K-RAS, B-RAF somatic mutations and EGFR mRNA expression in tumor specimens from advanced NSCLC patients as predicators of the efficacy of icotinib hydrochloride. Methods We analyzed tumor paraffin-embedded specimens, which were obtained from 14 of 40 patients with advanced NSCLC who enrolled in the stage I clinical trial of icotinib hydrochloride. Somatic mutations were evaluated by mutant-enriched liquidchip (MEL) technology, and EGFR mRNA expression was measured by branched DNA liquidchip (MBL) technology. Results In the 14 specimens, seven patients showed EGFR mutations, exon 19 deletion (3/7) and exon 21 point mutation (4/7); and two patients showed K-RAS mutation. No mutations in EGFR exon 20. or B-RAF were detected. In patients with EGFR mutation, one patient developed progress disease (PD), three patients had stable disease (SD), two patients had partial responses (PR) and one patient had a complete response (CR). In patients with wild-type EGFR, four patients had PD, three patients acquired SD, and none had PR/CR (P=-0.0407). EGFR mutations were associated with better progress-free survival (PFS) (141 days vs. 61 days) but without a statistically significant difference (P=0.8597), and median overall survival (OS) (-〉449 days vs. 140 days). EGFR mRNA expression levels were evaluated (three high, eight moderate, one low, and two that can not be measured due to insufficient tumor tissue) and no statistically significant relationships was observed with response, PFS or OS. Conclusions The EGFR mutation rate was consistent with that reported in the Asian population, so the MEL technology is reliable for measuring EGFR mutation with high throughput and rapidity 展开更多
关键词 non-small cell lung cancer icotinib hydrochloride epidermal growth factor receptor somatic mutation messenger RNA
原文传递
盐酸吗啡和盐酸氢吗啡酮用于前列腺电切术后硬膜外镇痛效果的比较 被引量:28
4
作者 占乐云 夏中元 +3 位作者 张蕾 赵博 吴洋 侯家保 《医药导报》 CAS 2016年第8期858-860,共3页
目的 比较盐酸氢吗啡酮与盐酸吗啡在前列腺电切术后患者硬膜外镇痛的效果及不良反应。方法 ASAⅠ或Ⅱ级择期行经尿道前列腺电切术(TURP)患者,随机分为盐酸吗啡组(n=45),盐酸氢吗啡酮组(n=47),术后接受硬膜外镇痛。采用视觉模拟(... 目的 比较盐酸氢吗啡酮与盐酸吗啡在前列腺电切术后患者硬膜外镇痛的效果及不良反应。方法 ASAⅠ或Ⅱ级择期行经尿道前列腺电切术(TURP)患者,随机分为盐酸吗啡组(n=45),盐酸氢吗啡酮组(n=47),术后接受硬膜外镇痛。采用视觉模拟(VAS)评分、Ramsay评分评价两组术后6,24 h镇痛、镇静效果及不良反应。结果 6 h内,盐酸氢吗啡酮组患者对疼痛耐受及舒适感优于盐酸吗啡组(P〈0.05)[(2.9±0.3)分比(1.3±0.2)分,(2.4±0.3)分比(0.9±0.2)],而在术后6~12 h盐酸吗啡组患者对疼痛和舒适感受较盐酸氢吗啡酮组好(P〈0.05)[(3.4±0.3)分比(5.4±0.3)分,(3.3±0.2)分比(5.7±0.4)分],24 h后两者效果差异无统计学意义(P〉0.05);不良反应发生率两者均差异无统计学意义(P〉0.05)。结论 TURP术后硬膜外镇痛,6 h内盐酸氢吗啡酮缓解患者疼痛和舒适感优于盐酸吗啡。 展开更多
关键词 氢吗啡酮 盐酸 吗啡 盐酸 镇痛 电切术 前列腺
下载PDF
盐酸埃克替尼治疗EGFR突变状态明确的晚期非小细胞肺癌的临床观察 被引量:28
5
作者 纪春东 于秀芹 赖永新 《河北医学》 CAS 2017年第1期100-102,共3页
目的:探讨EGFR突变状态检查明确的晚期非小细胞肺癌患者应用盐酸埃克替尼治疗的效果与安全性。方法:选取2013~2016年收治的EGFR基因突变状态确定的晚期非小细胞肺癌患者90例,随机平均分为两组,观察组选择埃克替尼治疗,对照组选择吉非替... 目的:探讨EGFR突变状态检查明确的晚期非小细胞肺癌患者应用盐酸埃克替尼治疗的效果与安全性。方法:选取2013~2016年收治的EGFR基因突变状态确定的晚期非小细胞肺癌患者90例,随机平均分为两组,观察组选择埃克替尼治疗,对照组选择吉非替尼治疗。结果:治疗6周后两组患者的疾病有效率与疾病控制率不存在明显差异(P>0.05)。两组患者疾病进展时间无显著差异(P>0.05),观察组患者平均生存时间相比对照组明显延长(P<0.05)。两组患者均无严重毒副反应,不良反应发生率无显著差异(P>0.05)。结论:盐酸埃克替尼治疗EGFR明确基因突变状态的非小细胞肺癌患者,能够取得与进口吉非替尼相近的临床治疗效果,还可以相对延长生存时间,安全性较好,疗效可以肯定。 展开更多
关键词 盐酸埃克替尼 EGFR突变 晚期非小细胞肺癌
下载PDF
盐酸羟考酮联合帕瑞昔布钠对瑞芬太尼复合麻醉患者手术后痛觉过敏的影响 被引量:25
6
作者 王志红 赵莉 +4 位作者 杨毅 陈刚 闫磊 喻红彪 徐桂萍 《医药导报》 CAS 2016年第9期978-981,共4页
目的观察盐酸羟考酮联合帕瑞昔布钠对瑞芬太尼复合麻醉患者手术后痛觉过敏的影响及安全性。方法择期行腹腔镜子宫肌瘤剥除手术患者88例,随机分为对照组、盐酸羟考酮组、帕瑞昔布钠组和联合组,各22例,分别在手术结束前30 min静脉注射0.9... 目的观察盐酸羟考酮联合帕瑞昔布钠对瑞芬太尼复合麻醉患者手术后痛觉过敏的影响及安全性。方法择期行腹腔镜子宫肌瘤剥除手术患者88例,随机分为对照组、盐酸羟考酮组、帕瑞昔布钠组和联合组,各22例,分别在手术结束前30 min静脉注射0.9%氯化钠溶液10 m L,盐酸羟考酮0.1 mg·kg-1,帕瑞昔布钠40 mg和盐酸羟考酮0.1 mg·kg-1联合帕瑞昔布钠40 mg。观察并记录手术后30 min,1,2,4,8 h的视觉模拟评分(VAS),同时记录各组手术后躁动、寒战、恶心呕吐和24 h内追加镇痛药物的例数。结果与对照组比较,盐酸羟考酮组、帕瑞昔布钠组和联合组手术后各时点VAS评分均明显降低(均P<0.05),联合组手术后各时点VAS评分均明显低于盐酸羟考酮组和帕瑞昔布钠组(均P<0.05)。联合组手术后躁动和寒战发生率分别为0.0%,5.0%,均明显低于对照组(45.0%,23.0%)(P<0.05);联合组手术后无镇痛药追加患者,对照组、盐酸羟考酮组和帕瑞昔布钠组镇痛药追加患者分别有12,5,5例(P<0.05)。结论盐酸羟考酮联合帕瑞昔布钠能有效减轻瑞芬太尼复合麻醉患者手术后痛觉过敏,降低手术后躁动的发生率。 展开更多
关键词 羟考酮 盐酸 帕瑞昔布钠 瑞芬太尼 痛觉过敏
下载PDF
Effects of penehyclidine hydrochloride in small intestinal damage caused by limb ischemia-reperfusion 被引量:25
7
作者 Yan Zhang Yu-Fang Leng Xing Xue Yue Zhang Tao Wang Yu-Qing Kang 《World Journal of Gastroenterology》 SCIE CAS CSCD 2011年第2期254-259,共6页
AIM:To investigate the protective effect of penehyclidine hydrochloride post-conditioning in the damage to the barrier function of the small intestinal mucosa caused by limb ischemia-reperfusion(LIR) injury. METHODS:M... AIM:To investigate the protective effect of penehyclidine hydrochloride post-conditioning in the damage to the barrier function of the small intestinal mucosa caused by limb ischemia-reperfusion(LIR) injury. METHODS:Male Wistar rats were randomly divided into three groups(36 rats each) :the sham-operation group(group S) ,lower limb ischemia-reperfusion group(group LIR) ,and penehyclidine hydrochloride postconditioning group(group PHC) .Each group was divided into subgroups(n=6 in each group) according to ischemic-reperfusion time,i.e.immediately 0 h(T1) ,1 h(T2) ,3 h(T3) ,6 h(T4) ,12 h(T5) ,and 24 h(T6) .Bilateral hind-limb ischemia was induced by rubber band application proximal to the level of the greater trochanter for 3 h.In group PHC,0.15 mg/kg of penehyclidine hydrochloride was injected into the tail vein immediately after 3 h of bilateral hind-limb ischemia.The designated rats were sacrificed at different time-points of reperfusion;diamine oxidase(DAO) ,superoxide dismutase(SOD) activity,myeloperoxidase(MPO) of small intestinal tissue,plasma endotoxin,DAO,tumor necrosis factor-α(TNF-α) ,and interleukin(IL) -10 in serum were detected in the rats. RESULTS:The pathological changes in the small intestine were observed under light microscope.The levels of MPO,endotoxin,serum DAO,and IL-10 at T1-T6,and TNF-αlevel at T1-T4 increased in groups LIR and PHC(P<0.05) compared with those in group S,but tissue DAO and SOD activity at T1-T6 decreased(P<0.05) .In group PHC,the tissue DAO and SOD activity at T2-T6,and IL-10 at T2-T5 increased to higher levels than those in group LIR(P<0.05) ;however,the levels of MPO,endotoxin,and DAO in the blood at T2-T6,and TNF-αat T2 and T4 decreased(P<0.05) . CONCLUSION:Penehyclidine hydrochloride post-conditioning may reduce the permeability of the small intestines after LIR.Its protection mechanisms may be related to inhibiting oxygen free radicals and inflammatory cytokines for organ damage. 展开更多
关键词 Penehyelidine hydrochloride POST-CONDITIONING Limb ischemia-reperfusion injury Small intestine PROTECTION
下载PDF
姜辣素在2种呕吐动物模型中止呕作用机制的探讨 被引量:22
8
作者 王耀霞 杨志宏 +2 位作者 岳旺 刘占涛 韩庆方 《沈阳药科大学学报》 CAS CSCD 北大核心 2009年第2期134-137,164,共5页
目的开发姜的止呕制剂,弥补临床上5-羟色胺Ⅲ亚型受体(5-hydroxytryptamine-3 receptor,5-HT3)及神经激肽Ⅰ亚型受体(neurokinin-1 receptor,NK1)拮抗剂靶点单一、价格昂贵、毒性及不良反应大等缺点。方法用特异性5-HT3受体激动剂1-phen... 目的开发姜的止呕制剂,弥补临床上5-羟色胺Ⅲ亚型受体(5-hydroxytryptamine-3 receptor,5-HT3)及神经激肽Ⅰ亚型受体(neurokinin-1 receptor,NK1)拮抗剂靶点单一、价格昂贵、毒性及不良反应大等缺点。方法用特异性5-HT3受体激动剂1-phenylbiguanide hydrochloride(PBG)和多巴胺受体激动剂阿朴吗啡(apomorphine)建立新型水貂呕吐模型和经典大鼠异嗜模型,观察姜辣素对水貂呕吐行为和大鼠异嗜高岭土行为的抑制作用。结果姜辣素对水貂呕吐行为和大鼠异嗜高岭土行为均表现出显著的抑制作用(P<0.05),并呈现一定的量效关系。结论姜辣素有止呕作用,其止呕机制可能涉及到5-羟色胺和多巴胺受体系统;姜辣素在研究天然多靶点新型止呕药方面具有潜在的应用价值。 展开更多
关键词 姜辣素 呕吐 水貂 5-羟色胺Ⅲ亚型受体激动剂 1-phenylbiguanide hydrochloride
下载PDF
盐酸哌甲酯控释片治疗儿童注意缺陷多动障碍疗效 被引量:22
9
作者 陈敏 华丽 +3 位作者 刘琳 徐璐 郝燕 侯凌 《医药导报》 CAS 2015年第10期1318-1321,共4页
目的:研究盐酸哌甲酯控释片治疗儿童注意缺陷多动障碍( ADHD)的疗效。方法将72例ADHD患儿随机分成治疗组40例和对照组32例。治疗组给予盐酸哌甲酯控释片,初始剂量为每天0.5 mg·kg-1,根据患儿病情和耐受程度逐步增加至每天0.8... 目的:研究盐酸哌甲酯控释片治疗儿童注意缺陷多动障碍( ADHD)的疗效。方法将72例ADHD患儿随机分成治疗组40例和对照组32例。治疗组给予盐酸哌甲酯控释片,初始剂量为每天0.5 mg·kg-1,根据患儿病情和耐受程度逐步增加至每天0.8~1.0 mg·kg-1,持续治疗3个月。对照组给予盐酸托莫西汀胶囊,初始剂量为每天0.5 mg·kg-1,根据患儿病情和耐受程度逐步增加至每天1.2~1.4 mg·kg-1,均于每日早餐后单次服药,疗程3个月。治疗前和治疗第12周进行韦氏智力测验、视听整合连续测试(IVA-CPT)、注意缺陷多动症状评估量表(SNAP-Ⅳ)和不良反应症状量表(TESS)评定。结果两组治疗后儿童注意缺陷及多动症状明显改善,韦氏智测评分明显增高(P〈0.05),SNAP-IV评分明显降低(P〈0.05),IVA-CPT评分明显提高(P〈0.05)。治疗组多动分数变化大于对照组(P〈0.05);治疗组听觉注意、视觉注意变化得分大于对照组( P〈0.05);治疗组食欲下降10例,对照组14例。治疗组嗜睡1例,对照组5例( P〈0.05)。治疗组入睡困难6例,对照组1例( P〈0.05)。治疗组1例在治疗第4个月出现一过性抽动症状。结论盐酸哌甲酯控释片和盐酸托莫西汀均能快速有效改善儿童注意缺陷和多动症状,同时提高患儿的学习功能,而盐酸哌甲酯控释片改善速度更快。 展开更多
关键词 哌甲酯控释片 盐酸 托莫西汀 盐酸 注意缺陷多动障碍
下载PDF
盐酸罗哌卡因联合舒芬太尼硬膜外麻醉无痛分娩临床观察 被引量:22
10
作者 冯定祥 陈燕 +1 位作者 陈宏靖 曹亦倩 《中国妇幼健康研究》 2017年第S1期428-429,共2页
目的:探究在无痛分娩过程中应用盐酸罗哌卡因联合舒芬太尼硬膜外麻醉的效果。方法:选取我院收治的100例行无痛分娩的产妇,随机分为观察组和对照组,观察组产妇联合应用盐酸罗哌卡因、舒芬太尼麻醉,对照组产妇联合应用布比卡因、舒芬太尼... 目的:探究在无痛分娩过程中应用盐酸罗哌卡因联合舒芬太尼硬膜外麻醉的效果。方法:选取我院收治的100例行无痛分娩的产妇,随机分为观察组和对照组,观察组产妇联合应用盐酸罗哌卡因、舒芬太尼麻醉,对照组产妇联合应用布比卡因、舒芬太尼麻醉,观察并记录两组产妇的分娩情况。结果:观察组产妇第一、二产程时间明显少于对照组;两组产妇产后平均出血量组间数据差异不大;观察组剖宫产率(4.0%)明显低于对照组剖宫产率(16.0%)。结论:无痛分娩过程联合盐酸罗哌卡因、舒芬太尼进行硬膜外麻醉,镇痛效果较好,产妇顺产率明显提高,值得临床推广应用。 展开更多
关键词 盐酸罗哌卡因 舒芬太尼 硬膜外麻醉 无痛分娩
下载PDF
Effect of NF-κB inhibitor PDTC on VEGF and endostatin expression of mice with Lewis lung cancer 被引量:19
11
作者 Ping Gao Ya-Jie Gao Hong-Lu Liang 《Asian Pacific Journal of Tropical Medicine》 SCIE CAS 2015年第3期220-224,共5页
Objective:To investigate the effects of NF-κB inhibitor pyrrolidine dithiocarbamate hydrochloride(PDTC) on vascular endothelial growth factor(VEGF) and endostatin expression in mice with Lewis lung cance;and its mech... Objective:To investigate the effects of NF-κB inhibitor pyrrolidine dithiocarbamate hydrochloride(PDTC) on vascular endothelial growth factor(VEGF) and endostatin expression in mice with Lewis lung cance;and its mechanism.Methods:Mice survival rate and anti-tumor effects were observed in different concentrations of NF-κB inhibitor PDTC after the Lewis lung cancer mice model was established.VEGF and endostatin expressions were detected by immunohistochemical assay.Results:Lewis lung cancer was be inhibited by 0.5 mg/kg.1.5 mg/kg and 3.0 mg/kg of NF-κB inhibitor PDTC(P<0.05).Microvessel density(MVD) in 0.5 mg/kg.1.5 mg/kg and 3.0 mg/kg NF-κB inhibitor PDTC groups were significantly lower than the control group(P<0.05).Immunohistochemical assay results showed that VEGF and endostatin expressions in the 0.5 mg/kg.1.5 mg/kg and 3.0 mg/kg NF-κB inhibitor PDTC groups were significantly lower than the control group(P<0.05).Western blot results also showed that NF-κB inhibitor PDTC could inhibit VEGF and endostatin expressions in tumor tissues.Conclusions:NF-κB inhibitor PDTC can inhibit tumor formation and reduce tumor angiogenesis in mice with Lewis lung cancer;and its mechanism maybe associated to VEGF and endostatin down-regulation. 展开更多
关键词 PDTC MICE with Lewis lung cancer VASCULAR density VASCULAR endothelial growth factor ENDOSTATIN PYRROLIDINE DITHIOCARBAMATE hydrochloride
下载PDF
盐酸羟考酮和舒芬太尼对神经外科手术全身麻醉患者苏醒质量的影响比较 被引量:18
12
作者 王培 范婷 《医药导报》 CAS 2017年第5期497-500,共4页
目的观察在神经外科手术中舒芬太尼或盐酸羟考酮对全身麻醉患者苏醒质量的影响。方法择期在全身麻醉下行经乙状窦入路显微血管减压术患者120例,随机分为4组,分别为羟考酮0.03 mg·kg^(-1) 组(H1组)、羟考酮0.05 mg·kg^(-1) 组... 目的观察在神经外科手术中舒芬太尼或盐酸羟考酮对全身麻醉患者苏醒质量的影响。方法择期在全身麻醉下行经乙状窦入路显微血管减压术患者120例,随机分为4组,分别为羟考酮0.03 mg·kg^(-1) 组(H1组)、羟考酮0.05 mg·kg^(-1) 组(H2组)、羟考酮0.08 mg·kg^(-1) 组(H3组)、舒芬太尼0.08μg·kg^(-1) 组(S组),各30例。全身麻醉诱导后瑞芬太尼4 ng·m L^(-1) 靶控输注,丙泊酚5~6 mg·kg^(-1) ·h^(-1) 泵注维持麻醉,使脑电双频指数(BIS)维持在40~60。开始缝合硬脑膜时,按照不同剂量给予舒芬太尼或盐酸羟考酮静脉滴注。记录4组患者手术结束时BIS值,丙泊酚总量,麻醉维持时间,手术持续时间,给药至手术结束时间,手术结束至自主呼吸恢复时间、清醒时间及拔管时间,手术结束后10,20,30 min时患者镇痛口述分级评分(VRS)和镇静评分(SS)及不良反应。结果 4组患者术后10 min时VRS评分差异无统计学意义。术后20,30 min时H1组评分均高于H2组、H3组。4组患者术后10 min时SS评分差异无统计学意义,术后20 min时H1组评分低于H3组,S组评分低于H2组、H3组,术后30 min时H3组评分高于H1组、H2组、S组。结论神经外科手术中给予舒芬太尼0.08μg·kg^(-1) 或盐酸羟考酮0.05 mg·kg^(-1) 均可以获得良好的麻醉苏醒质量。 展开更多
关键词 舒芬太尼 羟考酮 盐酸 手术 神经外科 麻醉 全身 苏醒质量
下载PDF
Repurposing of clinically approved drugs for treatment of coronavirus disease 2019 in a 2019-novel coronavirus-related coronavirus model 被引量:17
13
作者 Hua-Hao Fan Li-Qin Wang +5 位作者 Wen-Li Liu Xiao-Ping An Zhen-Dong Liu Xiao-Qi He Li-Hua Song Yi-Gang Tong 《Chinese Medical Journal》 SCIE CAS CSCD 2020年第9期1051-1056,共6页
Background:Medicines for the treatment of 2019-novel coronavirus(2019-nCoV)infections are urgently needed.However,drug screening using live 2019-nCoV requires high-level biosafety facilities,which imposes an obstacle ... Background:Medicines for the treatment of 2019-novel coronavirus(2019-nCoV)infections are urgently needed.However,drug screening using live 2019-nCoV requires high-level biosafety facilities,which imposes an obstacle for those institutions without such facilities or 2019-nCoV.This study aims to repurpose the clinically approved drugs for the treatment of coronavirus disease 2019(COVID-19)in a 2019-nCoV-related coronavirus model.Methods:A 2019-nCoV-related pangolin coronavirus GX_P2V/pangolin/2017/Guangxi was described.Whether GX_P2V uses angiotensin-converting enzyme 2(ACE2)as the cell receptor was investigated by using small interfering RNA(siRNA)-mediated silencing of ACE2.The pangolin coronavirus model was used to identify drug candidates for treating 2019-nCoV infection.Two libraries of 2406 clinically approved drugs were screened for their ability to inhibit cytopathic effects on Vero E6 cells by GX_P2V infection.The anti-viral activities and anti-viral mechanisms of potential drugs were further investigated.Viral yields of RNAs and infectious particles were quantified by quantitative real-time polymerase chain reaction(qRT-PCR)and plaque assay,respectively.Results:The spike protein of coronavirus GX_P2V shares 92.2%amino acid identity with that of 2019-nCoV isolate Wuhanhu-1,and uses ACE2 as the receptor for infection just like 2019-nCoV.Three drugs,including cepharanthine(CEP),selamectin,and mefloquine hydrochloride,exhibited complete inhibition of cytopathic effects in cell culture at 10μmol/L.CEP demonstrated the most potent inhibition of GX_P2V infection,with a concentration for 50%of maximal effect[EC50]of 0.98μmol/L.The viral RNA yield in cells treated with 10μmol/L CEP was 15,393-fold lower than in cells without CEP treatment([6.48±0.02]×10-4vs.1.00±0.12,t=150.38,P<0.001)at 72 h post-infection(p.i.).Plaque assays found no production of live viruses in media containing 10μmol/L CEP at 48 h p.i.Furthermore,we found CEP had potent anti-viral activities against both viral entry(0.46±0.12,vs.1.00� 展开更多
关键词 Coronavirus disease 2019 2019-Novel coronavirus CEPHARANTHINE SELAMECTIN Mefloquine hydrochloride
原文传递
地佐辛与盐酸右美托咪定预防小儿术后躁动的效果比较 被引量:17
14
作者 魏会霞 罗向红 《医药导报》 CAS 北大核心 2018年第1期67-70,共4页
目的探讨地佐辛与盐酸右美托咪定预防小儿术后躁动的效果及安全性。方法择期行包皮套扎术患儿90例,随机分为地佐辛组、右美托咪定组和对照组,每组30例,均采用全身麻醉联合阴茎背神经阻滞麻醉。地佐辛组麻醉诱导后静脉泵注地佐辛0.1 mg&#... 目的探讨地佐辛与盐酸右美托咪定预防小儿术后躁动的效果及安全性。方法择期行包皮套扎术患儿90例,随机分为地佐辛组、右美托咪定组和对照组,每组30例,均采用全身麻醉联合阴茎背神经阻滞麻醉。地佐辛组麻醉诱导后静脉泵注地佐辛0.1 mg·kg^(-1);右美托咪定组麻醉诱导后静脉泵注盐酸右美托咪定0.5μg·kg^(-1);对照组麻醉诱导后静脉泵注等剂量0.9%氯化钠注射液。观察患儿躁动发生率、手术后苏醒时间、手术中追加丙泊酚的量及手术结束后6 h内的不良反应。结果 3组患儿均顺利完成手术,手术后苏醒时间差异无统计学意义(P>0.05);地佐辛组、右美托咪定组和对照组手术后躁动发生率分别为3.33%,0.00%和46.67%(P<0.05),3组患儿术中均未追加丙泊酚,术后6 h内均未见明显不良反应。结论地佐辛与盐酸右美托咪定均可有效预防患儿术后躁动,无明显不良反应,临床可安全使用。 展开更多
关键词 地佐辛 右美托咪定 盐酸 躁动 麻醉
下载PDF
盐酸帕罗西汀辅助治疗老年溃疡性结肠炎伴焦虑抑郁40例 被引量:17
15
作者 李楠 卢艳如 《医药导报》 CAS 2015年第7期903-906,共4页
目的观察盐酸帕罗西汀辅助治疗老年溃疡性结肠炎(UC)伴焦虑/抑郁的疗效。方法将80例老年UC伴焦虑/抑郁患者采用随机数字表法随机分为治疗组及对照组各40例,对照组轻度UC患者给予美沙拉嗪肠溶片1 g,tid,po;中度UC患者给予美沙拉嗪肠溶片1... 目的观察盐酸帕罗西汀辅助治疗老年溃疡性结肠炎(UC)伴焦虑/抑郁的疗效。方法将80例老年UC伴焦虑/抑郁患者采用随机数字表法随机分为治疗组及对照组各40例,对照组轻度UC患者给予美沙拉嗪肠溶片1 g,tid,po;中度UC患者给予美沙拉嗪肠溶片1 g,qid,po。足量治疗2周效果较差者加用醋酸泼尼松片10 mg,qid,po;治疗组在对照组基础上加用盐酸帕罗西汀片,起始10 mg·d-1,3 d后增加至20 mg·d-1,疗程2个月。治疗期间禁饮酒、咖啡及辛辣刺激性食物;每2周复诊1次。治疗前后对每例患者行UC临床及肠镜表现Mayo综合评分、汉密尔顿焦虑/抑郁(HAMA/HAMD)评分测试,比较治疗后的改善情况。结果治疗组治疗后Mayo综合评分较对照组显著下降,改善总有效率明显高于对照组(P<0.05);治疗组治疗后HAMA、HAMD评分均较对照组明显降低(均P<0.01)。结论帕罗西汀辅助治疗老年UC伴焦虑/抑郁,临床和肠镜综合表现以及焦虑/抑郁均有明显改善。 展开更多
关键词 帕罗西汀 盐酸 结肠炎 溃疡性 焦虑 抑郁 老年患者
下载PDF
盐酸环喷托酯滴眼液和阿托品对远视儿童散瞳验光效果的比较 被引量:15
16
作者 何花 王平 《医药导报》 CAS 2010年第9期1162-1165,共4页
目的比较盐酸环喷托酯滴眼液与阿托品对远视儿童散瞳验光效果的影响,以评估盐酸环喷托酯滴眼液的临床使用价值。方法对89例178眼远视儿童(3~12岁),先用1%盐酸环喷托酯滴眼液,后用1%硫酸阿托品眼用凝胶进行散瞳验光。分析比较不同年龄... 目的比较盐酸环喷托酯滴眼液与阿托品对远视儿童散瞳验光效果的影响,以评估盐酸环喷托酯滴眼液的临床使用价值。方法对89例178眼远视儿童(3~12岁),先用1%盐酸环喷托酯滴眼液,后用1%硫酸阿托品眼用凝胶进行散瞳验光。分析比较不同年龄组儿童的散瞳验光结果、瞳孔直径和残余调节量,并观察两种散瞳药物的全身不良反应。结果 86眼单纯性远视的球镜度数两种药物验光结果相同和相差≤0.50D者71眼,符合率为82.6%;92眼复性远视的球镜度数两种药物验光结果相同和相差≤0.50D者74眼,符合率为80.4%,柱镜度数两种药物验光结果相同和相差≤0.50D者77眼,符合率为83.7%,散光轴向相同和相差≤5°者77眼,符合率为83.7%。3个年龄组间的球镜、柱镜和散光轴向符合率均差异无显著性(P>0.05)。3个年龄组1%盐酸环喷托酯滴眼液和1%硫酸阿托品眼用凝胶充分散瞳后的瞳孔大小和残余调节量均差异无显著性(P>0.05)。1%盐酸环喷托酯滴眼液全身不良反应的发生率为3.4%,低于硫酸阿托品(13.5%)。结论盐酸环喷托酯滴眼液是一种强效、快速且安全的睫状肌麻痹药,临床上能代替阿托品用于远视儿童的散瞳验光。 展开更多
关键词 环喷托酯 盐酸 阿托品 睫状肌麻痹 远视 儿童
下载PDF
度洛西汀与舍曲林治疗老年期抑郁症的对照研究 被引量:15
17
作者 李宝珠 李洪英 《中外医学研究》 2011年第27期9-11,共3页
目的观察度洛西汀与舍曲林治疗老年抑郁症的临床疗效及安全性。方法将76例符合ICD-10抑郁症诊断标准的老年抑郁症患者随机分为两组,应用度洛西汀和舍曲林各38例进行随机对照研究,治疗时间为8周。疗效采用汉密尔顿焦虑量表(HAMA)和汉密... 目的观察度洛西汀与舍曲林治疗老年抑郁症的临床疗效及安全性。方法将76例符合ICD-10抑郁症诊断标准的老年抑郁症患者随机分为两组,应用度洛西汀和舍曲林各38例进行随机对照研究,治疗时间为8周。疗效采用汉密尔顿焦虑量表(HAMA)和汉密尔顿抑郁量表(HAMD)进行评定,不良反应采用副反应量表(TESS)进行评定。结果完成8周治疗后,两组间总体疗效比较差异无统计学意义,HAMD和HAMA总分治疗前后比较差异有统计学意义(P<0.05),两组间比较差异无统计学意义,但焦虑/躯体化、睡眠障碍等因子分比较,两组间差异有统计学意义,两组间不良反应比较差异无统计学意义,但度洛西汀起效快。结论度洛西汀治疗老年期抑郁症疗效好,安全性高,临床上特别适用于伴有躯体化症状的抑郁症老年患者。 展开更多
关键词 度洛西汀 舍曲林 老年抑郁症
下载PDF
丙醇-硫酸铵双水相体系萃取金(Ⅲ)-氯化物-罗丹明B 被引量:9
18
作者 高云涛 王伟 《化学研究与应用》 CAS CSCD 北大核心 2002年第3期320-321,共2页
A new method for the separation of ion association complex of gold(Ⅲ) chloride rhodamine B by aqueous biphasic extraction system of n propyl alcohol (NH 4) 2SO 4 water was investigated.The experimental results indica... A new method for the separation of ion association complex of gold(Ⅲ) chloride rhodamine B by aqueous biphasic extraction system of n propyl alcohol (NH 4) 2SO 4 water was investigated.The experimental results indicate that the method can extract Au(Ⅲ) in hydrochloride medium.The extraction ratios of Au(Ⅲ) is 99.2%.The proposed method can separate Au from Fe,Al,Pb,Zn,Ca,et al base metals and was used for the separation of synthetic sample and the samples of anode slime and place gold. 展开更多
关键词 双水相体系 丙醇 硫酸铵 罗丹明B 双水相萃取 盐酸 氯化物 分离
下载PDF
Neuroprotective effect of penehyclidine hydrochloride on focal cerebral ischemia-reperfusion injury 被引量:13
19
作者 Cuicui Yu Junke Wang 《Neural Regeneration Research》 SCIE CAS CSCD 2013年第7期622-632,共11页
Penehyclidine hydrochloride can promote microcirculation and reduce vascular permeability. However, the role of penehyclidine hydrochlodde in cerebral ischemia-reperfusion injury remains unclear. In this study, in viv... Penehyclidine hydrochloride can promote microcirculation and reduce vascular permeability. However, the role of penehyclidine hydrochlodde in cerebral ischemia-reperfusion injury remains unclear. In this study, in vivo middle cerebral artery occlusion models were established in experimental rats, and penehyclidine hydrochloride pretreatment was given via intravenous injection prior to model establishment. Tetrazolium chloride, terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate-biotin nick end labeling and immunohistochemical staining showed that, penehyclidine hydrochloride pretreatment markedly attenuated neuronal histopathological changes in the cortex, hippocampus and striatum, reduced infarction size, increased the expression level of BcI-2, decreased the expression level of caspase-3, and inhibited neuronal apoptosis in rats with cerebral ischemia-reperfusion injury. Xanthine oxidase and thiobarbituric acid chromogenic results showed that penehyclidine hydrochloride upregulated the activity of superoxide dismutase and downregulated the concentration of malondialdehyde in the ischemic cerebral cortex and hippocampus, as well as reduced the concentration of extracellular excitatory amino acids in rats with cerebral ischemia-reperfusion injury. In addition, penehyclidine hydrochloride inhibited the expression level of the NR1 subunit in hippocampal nerve cells in vitro following oxygen-glucose deprivation, as detected by PCR. Experimental findings indicate that penehyclidine hydrochloride attenuates neuronal apoptosis and oxidative stress injury after focal cerebral ischemia-reperfusion, thus exerting a neuroprotective effect. 展开更多
关键词 neural regeneration brain injury penehyclidine hydrochloride cerebral ischemia-reperfusion injuryischemic cerebrovascular disease APOPTOSIS excitatory amino acid oxygen free radicals superoxide dismutase N-methyI-D-aspartate receptor middle cerebral artery occlusion oxygen-glucose deprivation photographs-containing paper NEUROREGENERATION
下载PDF
女性抑郁症与性激素水平的关系研究 被引量:11
20
作者 平菁 毛富强 《天津医科大学学报》 2007年第3期436-437,439,共3页
目的:探讨女性抑郁症与性激素水平的关系。方法:用化学发光法测定30例抑郁症患者治疗前、后血清雌二醇、孕酮、睾酮、促甲状腺激素水平,并与30例正常对照比较。结果:女性抑郁症患者治疗前,雌二醇、游离T4、睾酮和孕酮水平均显著低于正... 目的:探讨女性抑郁症与性激素水平的关系。方法:用化学发光法测定30例抑郁症患者治疗前、后血清雌二醇、孕酮、睾酮、促甲状腺激素水平,并与30例正常对照比较。结果:女性抑郁症患者治疗前,雌二醇、游离T4、睾酮和孕酮水平均显著低于正常对照,促甲状腺激素极显著高于对照组。经盐酸氟西汀治疗后,雌二醇、游离T4、睾酮和孕酮含量显著升高;促甲状腺激素显著降低。结论:女性抑郁症患者存在性激素水平显著改变,尤其雌二醇极显著偏低,与抑郁症发生关系极为密切。 展开更多
关键词 抑郁症 性激素 盐酸氟西汀 女性
下载PDF
上一页 1 2 250 下一页 到第
使用帮助 返回顶部